INDIVIOR ORD USD0.50
INDIVIOR ORD USD0.50
- GBX (-)
- 15 min delayed data - London Stock Exchange
Open: -
Change: -
Volume: -
Low: -
High: -
High / Low range: -
Type: Stocks
Ticker: INDV
ISIN: GB00BN4HT335

INVVY CLASS ACTION ALERT: Hagens Berman Alerts Indivior PLC (INVVY) Investors to Securities Fraud Class Action, Encourages Investors With Losses in Excess of $50,000 to Contact the Firm

  • 139
INVVY CLASS ACTION ALERT: Hagens Berman Alerts Indivior PLC (INVVY) Investors to Securities Fraud Class Action, Encourages Investors With Losses in Excess of $50,000 to Contact the Firm

PR Newswire

SAN FRANCISCO, April 25, 2019 /PRNewswire/ -- Hagens Berman Sobol Shapiro LLP, with 9 offices in 8 cities around the country and 80 attorneys, alerts Indivior PLC (OTC: INVVY) investors to the securities fraud class action pending in the United States District Court for the District of New Jersey.

Hagens Berman Sobol Shapiro LLP (PRNewsfoto/Hagens Berman Sobol Shapiro LLP)

If you purchased or otherwise acquired Indivior securities between March 10, 2015 and April 9, 2019 (the "class period") and suffered substantial losses (in excess of $50,000), you may qualify to be a lead plaintiff – one who selects and oversees the attorneys prosecuting the case.

If you wish to serve as lead plaintiff in this class action, you must move the Court no later than June 24, 2019 (the "Lead Plaintiff deadline").  Contact Hagens Berman immediately for more information about the case and being a lead plaintiff:

https://www.hbsslaw.com/cases/INVVY

or contact Reed Kathrein, who is leading the firm's investigation, by calling 510-725-3000 or emailing

[email protected].

According to the complaint Defendants misled investors during the class period by concealing:
(1) Indivior and its executives engaged in an illicit nationwide scheme to increase prescriptions of Suboxone Film; (2) Indivior illegally obtained billions of dollars in revenue from Suboxone Film prescriptions by deceiving health care providers and health care benefit programs; and, (3) as a result of Defendants' misconduct, Indivior would face felony charges.

When the Department of Justice filed a criminal indictment against the Company on April 9, 2019, the price of Indivior securities fell sharply lower.

"We're focused on investors' losses, whether the Company and senior management deceived health care providers and health care benefit programs about the safety of Suboxone Film and, if so, the extent to which investors may have also been misled," said Hagens Berman partner Reed Kathrein.

Whistleblowers:  Persons with non-public information regarding Indivior should consider their options to help in the investigation or take advantage of the SEC Whistleblower program.  Under the new program, whistleblowers who provide original information may receive rewards totaling up to 30 percent of any successful recovery made by the SEC.  For more information, call Reed Kathrein at 510-725-3000 or email [email protected].

About Hagens Berman
Hagens Berman is a national investor-rights law firm headquartered in Seattle, Washington with 80 attorneys in 9 offices across the country.  The Firm represents investors, whistleblowers, workers and consumers in complex litigation.  More about the firm and its successes can be found at www.hbsslaw.com.  For the latest news visit our newsroom or follow us on Twitter at @classactionlaw.

Contact:
Reed Kathrein, 510-725-3000

 

Cision View original content to download multimedia:http://www.prnewswire.com/news-releases/invvy-class-action-alert-hagens-berman-alerts-indivior-plc-invvy-investors-to-securities-fraud-class-action-encourages-investors-with-losses-in-excess-of-50-000-to-contact-the-firm-300838829.html

SOURCE Hagens Berman Sobol Shapiro LLP

PR Newswire
PR Newswire

PR Newswire's news distribution, targeting, monitoring and marketing solutions help you connect and engage with target audiences across the globe.